期刊文献+

布洛芬联合艾拉莫德治疗类风湿关节炎的效果 被引量:5

Effect of ibuprofen combined with iguratimod in the treatment of rheumatoid arthritis
下载PDF
导出
摘要 目的观察布洛芬联合艾拉莫德治疗类风湿关节炎(RA)的效果。方法选取2016年6月至2017年12月我院收治的RA患者50例,随机分成单用组和联合组,每组25例。单用组口服给予布洛芬片进行治疗,联合组在单用组的基础上给予艾拉莫德片进行联合治疗。连续治疗2个月后,比较两组患者的治疗效果。结果治疗后,两组患者的肿胀关节数、压痛关节数显著减少,晨僵时间显著缩短,且联合组优于单用组(P<0.01)。治疗后,两组患者的类风湿因子、红细胞沉降率和C-反应蛋白水平均显著降低,且联合组低于对照组(P<0.01)。联合组患者的缓解率高于单用组(P<0.05)。结论布洛芬联合艾拉莫德治疗RA能显著减轻关节疼痛等症状,减轻或完全缓解关节炎症,临床效果显著。 Objective To observe the clinical effect of ibuprofen and iguratimod on rheumatoid arthritis(RA). Methods From June 2016 to December 2017, 50 patients with RA in our hospital were randomly divided into single group and combined group, with 25 cases in each group. The single group was given orally ibuprofen tablets, while the combined group was given iguratimod on the basis of the single group. After 2 months of continuous treatment, the therapeutic effects of the two groups were compared. Results After treatment, the numbers of swollen joints and tender joints significantly reduced, and the morning stiffness time significantly shortened in the two groups, and those of the combined group were superior to the single group(P〈0.01). After treatment, the levels of rheumatoid factors, erythrocyte sedimentation rate and C-reactive protein in both groups significantly reduced, and those of the combined group were superior to the single group(P〈0.01). The remission rate of the combined group was higher than that of the single group(P〈0.05). Conclusion Ibuprofen combined with iguratimod in the treatment of RA can significantly reduce the joint pain and other symptoms,reduce or completely alleviate joint inflammation, and has significant clinical effects.
作者 苟自明 张斌 杜永波 吴彦超 董飞 GOU Zi-ming;ZHANG Bin;DU Yong-bo;WU Yan-chao;DONG Fei(Orthopedics and Traumatology Department,Traditional Chinese Medicine Hospital of Ningqiang County,Hanzhong 724400,China)
出处 《临床医学研究与实践》 2018年第26期43-44,共2页 Clinical Research and Practice
关键词 布洛芬 艾拉莫德 类风湿关节炎(RA) ibuprofen iguratimod rheumatoid arthritis (RA)
  • 相关文献

参考文献6

二级参考文献27

  • 1游运辉,吴彩玲,罗卉,左晓霞.右布洛芬片与布洛芬片治疗类风湿关节炎比较[J].中国新药与临床杂志,2005,24(3):227-229. 被引量:3
  • 2滕佳临,吕良敬,鲍春德,韩星海,孙凌云,徐建华,李兴福,吴华香.艾拉莫德治疗类风湿关节炎多中心随机双盲安慰剂对照研究[J].中华风湿病学杂志,2007,11(8):462-465. 被引量:17
  • 3Boyesen P, Haavardsholm EA, Ostergaard M, et al. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are inde- pendent predictors of subsequent radiographic progression [ J ]. Ann Rheum Dis, 2011,70( 1) :176-179.
  • 4Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis [ J]. Lan- cet, 2010, 376:1094-1108.
  • 5Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/Europe- an League Against Rheumatism collaborative initiative [ J ]. Arthritis Rheum, 2010, 62(9) :2569-2581.
  • 6Cohen S, Emery P. The American College of Rheumatology/Europe- an League Against Rheumatism Criteria for the Classification of Rheumatoid Arthritis:A Game Changer[J]. Arthritis Rheum, 2010, 62(9) :2592-2594.
  • 7Van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis-comparison of the 1987 ACR and 2010 ACR/ EULAR criteria[ J]. Arthritis Rheum, 2011,63 ( 1 ) :37-42.
  • 8Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid ar- thritis to target : recommendations of an international task force [ J ]. Ann Rheum Dis, 2010,69(4) :631-637.
  • 9Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommenda- tions for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs [ J ]. Ann Rheum Dis, 2010,69(6) :964-975.
  • 10Mucke HA.Iguratimod:a new disease-modifying antirheumatic drug[J].Drugs Today,2012,48(9):577-586.

共引文献1440

同被引文献84

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部